Asserter profile

TAKEDA PHARMACEUTICAL COMPANY LIMITED

operating company2 patents now2 ever1 case filed during tenure2 connections

Also seen as: Takeda Pharmaceutical Company Limited

Two-hop network

Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.

flowchart LR
    Ntakeda_pharmaceutical["TAKEDA PHARMACEUTICAL COMPANY LIMITED"]
    Nramachandran_kishore_depue_jeffrey_scott_reisch_helge_alfred["RAMACHANDRAN, KISHORE; DEPUE, JEFFREY S…"]
    Nshire_human_genetic_therapies["Shire Human Genetic Therapies, Inc."]
    Ntranskaryotic_therapies["Transkaryotic Therapies, Inc."]
    Nmeiyappan_muthuraman_norton_angela_w_concino_michael_f["Meiyappan, Muthuraman; Norton, Angela W…"]
    Nramachandran_kishore_depue_jeffrey_scott_reisch_helge_alfred ==>|"⚖️ 2025 · ASSIGNMENT OF ASSIGNOR'S INTEREST · 12527771"| Ntakeda_pharmaceutical
    Nshire_human_genetic_therapies -->|"2021 · Assignment · 8775146"| Ntakeda_pharmaceutical
    Ntranskaryotic_therapies -->|"2006 · Change of Name · 5733761"| Nshire_human_genetic_therapies
    Nmeiyappan_muthuraman_norton_angela_w_concino_michael_f -->|"2011 · Assignment · 8775146"| Nshire_human_genetic_therapies
    classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
    classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
    classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
    classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
    classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
    class Ntakeda_pharmaceutical focal
    class Nshire_human_genetic_therapies operating
    class Ntranskaryotic_therapies operating

Patents currently held (2)

Connected entities (2)

Correspondent attorneys (1)

Attorneys / firms recorded with USPTO when this entity received a patent. Recurrence is the signal — many firms do both NPE and operating-company patent work, so a single appearance doesn’t mean much.